+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Celiac Disease Drugs Market 2022-2026

  • PDF Icon

    Report

  • 120 Pages
  • July 2022
  • Region: Global
  • TechNavio
  • ID: 5454755
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The celiac disease drugs market is poised to grow by $601.57 mn during 2022-2026, accelerating at a CAGR of 16.95% during the forecast period. The report on the celiac disease drugs market provides a holistic analysis, of market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by higher consumption of gluten-containing food, increasing prevalence of celiac disease, and government initiatives.

The celiac disease drugs market analysis includes type segment and geographic landscape.

The celiac diseases drugs market is segmented as below:


By Type

  • The first line of treatment
  • The second line of treatment

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the inorganic growth strategies as one of the prime reasons driving the celiac diseases drugs market growth during the next few years. Also, a robust pipeline and rise in pharmaceutical expenditure will lead to sizable demand in the market.

The report on the celiac diseases drugs market covers the following areas:

  • Celiac diseases drugs market sizing
  • Celiac diseases drugs market forecast
  • Celiac diseases drugs market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading celiac diseases drugs market vendors that include 9 Meters Biopharma Inc., Adaptive Biotechnologies Corp., Almirall SA, Amgen Inc., AMYRA Biotech AG, Avaxia Biologics Inc., BioLineRx Ltd., Bristol Myers Squibb Co., Calypso Biotech, GlaxoSmithKline Plc, Glenmark Pharmaceuticals Ltd, Immunogenics LLC, Johnson and Johnson, Precigen Inc., Sanofi, Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., Vactech Oy, Zedira GmbH, and Artielle Immunotherapeutics Inc. Also, the celiac disease drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market through study, synthesis, and summation of data from multiple sources by analyzing key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Therapy
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by Therapy
5.1 Market segments
Exhibit 24: Chart on Therapy - Market share 2021-2026 (%)
Exhibit 25: Data Table on Therapy - Market share 2021-2026 (%)
5.2 Comparison by Therapy
Exhibit 26: Chart on Comparison by Therapy
Exhibit 27: Data Table on Comparison by Therapy
5.3 First line treatment - Market size and forecast 2021-2026
Exhibit 28: Chart on First line treatment - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on First line treatment - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on First line treatment - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on First line treatment - Year-over-year growth 2021-2026 (%)
5.4 Second line treatment - Market size and forecast 2021-2026
Exhibit 32: Chart on Second line treatment - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Second line treatment - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Second line treatment - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Second line treatment - Year-over-year growth 2021-2026 (%)
5.5 Market opportunity by Therapy
Exhibit 36: Market opportunity by Therapy ($ million)
6 Customer Landscape
6.1 Customer landscape overview
Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
7.1 Geographic segmentation
Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 40: Chart on Geographic comparison
Exhibit 41: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 Canada - Market size and forecast 2021-2026
Exhibit 62: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on Canada - Year-over-year growth 2021-2026 (%)
7.9 Germany - Market size and forecast 2021-2026
Exhibit 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
7.10 UK - Market size and forecast 2021-2026
Exhibit 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on UK - Year-over-year growth 2021-2026 (%)
7.11 France - Market size and forecast 2021-2026
Exhibit 74: Chart on France - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on France - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on France - Year-over-year growth 2021-2026 (%)
7.12 Market opportunity By Geographical Landscape
Exhibit 78: Market opportunity By Geographical Landscape ($ million)
8 Drivers, Challenges, and Trends
8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 79: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends
9 Vendor Landscape
9.1 Overview
9.2 Vendor landscape
Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 81: Overview on factors of disruption
9.4 Industry risks
Exhibit 82: Impact of key risks on business
10 Vendor Analysis
10.1 Vendors covered
Exhibit 83: Vendors covered
10.2 Market positioning of vendors
Exhibit 84: Matrix on vendor position and classification
10.3 Amgen Inc.
Exhibit 85: Amgen Inc. - Overview
Exhibit 86: Amgen Inc. - Product / Service
Exhibit 87: Amgen Inc. - Key offerings
10.4 AMYRA Biotech AG
Exhibit 88: AMYRA Biotech AG - Overview
Exhibit 89: AMYRA Biotech AG - Product / Service
Exhibit 90: AMYRA Biotech AG - Key offerings
10.5 BioLineRx Ltd.
Exhibit 91: BioLineRx Ltd. - Overview
Exhibit 92: BioLineRx Ltd. - Product / Service
Exhibit 93: BioLineRx Ltd. - Key offerings
10.6 Bristol Myers Squibb Co.
Exhibit 94: Bristol Myers Squibb Co. - Overview
Exhibit 95: Bristol Myers Squibb Co. - Product / Service
Exhibit 96: Bristol Myers Squibb Co. - Key offerings
10.7 Calypso Biotech
Exhibit 97: Calypso Biotech - Overview
Exhibit 98: Calypso Biotech - Product / Service
Exhibit 99: Calypso Biotech - Key offerings
10.8 GlaxoSmithKline Plc
Exhibit 100: GlaxoSmithKline Plc - Overview
Exhibit 101: GlaxoSmithKline Plc - Business segments
Exhibit 102: GlaxoSmithKline Plc - Key news
Exhibit 103: GlaxoSmithKline Plc - Key offerings
Exhibit 104: GlaxoSmithKline Plc - Segment focus
10.9 Immunogenics LLC
Exhibit 105: Immunogenics LLC - Overview
Exhibit 106: Immunogenics LLC - Product / Service
Exhibit 107: Immunogenics LLC - Key offerings
10.10 Johnson and Johnson
Exhibit 108: Johnson and Johnson - Overview
Exhibit 109: Johnson and Johnson - Business segments
Exhibit 110: Johnson and Johnson - Key news
Exhibit 111: Johnson and Johnson - Key offerings
Exhibit 112: Johnson and Johnson - Segment focus
10.11 Sanofi
Exhibit 113: Sanofi - Overview
Exhibit 114: Sanofi - Business segments
Exhibit 115: Sanofi - Key news
Exhibit 116: Sanofi - Key offerings
Exhibit 117: Sanofi - Segment focus
10.12 Takeda Pharmaceutical Co. Ltd.
Exhibit 118: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibit 119: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibit 120: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibit 121: Takeda Pharmaceutical Co. Ltd. - Key offerings
11 Appendix
11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 122: Inclusions checklist
Exhibit 123: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 124: Currency conversion rates for US$
11.4 Research methodology
Exhibit 125: Research methodology
Exhibit 126: Validation techniques employed for market sizing
Exhibit 127: Information sources
11.5 List of abbreviations
Exhibit 128: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Therapy
Exhibits 6: Executive Summary - Chart on Incremental Growth
Exhibits 7: Executive Summary - Data Table on Incremental Growth
Exhibits 8: Executive Summary - Chart on Vendor Market Positioning
Exhibits 9: Parent market
Exhibits 10: Market Characteristics
Exhibits 11: Offerings of vendors included in the market definition
Exhibits 12: Market segments
Exhibits 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits 17: Five forces analysis - Comparison between 2021 and 2026
Exhibits 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits 20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits 21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits 22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits 23: Chart on Market condition - Five forces 2021 and 2026
Exhibits 24: Chart on Therapy - Market share 2021-2026 (%)
Exhibits 25: Data Table on Therapy - Market share 2021-2026 (%)
Exhibits 26: Chart on Comparison by Therapy
Exhibits 27: Data Table on Comparison by Therapy
Exhibits 28: Chart on First line treatment - Market size and forecast 2021-2026 ($ million)
Exhibits 29: Data Table on First line treatment - Market size and forecast 2021-2026 ($ million)
Exhibits 30: Chart on First line treatment - Year-over-year growth 2021-2026 (%)
Exhibits 31: Data Table on First line treatment - Year-over-year growth 2021-2026 (%)
Exhibits 32: Chart on Second line treatment - Market size and forecast 2021-2026 ($ million)
Exhibits 33: Data Table on Second line treatment - Market size and forecast 2021-2026 ($ million)
Exhibits 34: Chart on Second line treatment - Year-over-year growth 2021-2026 (%)
Exhibits 35: Data Table on Second line treatment - Year-over-year growth 2021-2026 (%)
Exhibits 36: Market opportunity by Therapy ($ million)
Exhibits 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits 40: Chart on Geographic comparison
Exhibits 41: Data Table on Geographic comparison
Exhibits 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits 44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits 58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits 60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits 61: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits 62: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits 63: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits 64: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits 65: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits 72: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits 73: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits 74: Chart on France - Market size and forecast 2021-2026 ($ million)
Exhibits 75: Data Table on France - Market size and forecast 2021-2026 ($ million)
Exhibits 76: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibits 77: Data Table on France - Year-over-year growth 2021-2026 (%)
Exhibits 78: Market opportunity By Geographical Landscape ($ million)
Exhibits 79: Impact of drivers and challenges in 2021 and 2026
Exhibits 80: Overview on Criticality of inputs and Factors of differentiation
Exhibits 81: Overview on factors of disruption
Exhibits 82: Impact of key risks on business
Exhibits 83: Vendors covered
Exhibits 84: Matrix on vendor position and classification
Exhibits 85: Amgen Inc. - Overview
Exhibits 86: Amgen Inc. - Product / Service
Exhibits 87: Amgen Inc. - Key offerings
Exhibits 88: AMYRA Biotech AG - Overview
Exhibits 89: AMYRA Biotech AG - Product / Service
Exhibits 90: AMYRA Biotech AG - Key offerings
Exhibits 91: BioLineRx Ltd. - Overview
Exhibits 92: BioLineRx Ltd. - Product / Service
Exhibits 93: BioLineRx Ltd. - Key offerings
Exhibits 94: Bristol Myers Squibb Co. - Overview
Exhibits 95: Bristol Myers Squibb Co. - Product / Service
Exhibits 96: Bristol Myers Squibb Co. - Key offerings
Exhibits 97: Calypso Biotech - Overview
Exhibits 98: Calypso Biotech - Product / Service
Exhibits 99: Calypso Biotech - Key offerings
Exhibits 100: GlaxoSmithKline Plc - Overview
Exhibits 101: GlaxoSmithKline Plc - Business segments
Exhibits 102: GlaxoSmithKline Plc - Key news
Exhibits 103: GlaxoSmithKline Plc - Key offerings
Exhibits 104: GlaxoSmithKline Plc - Segment focus
Exhibits 105: Immunogenics LLC - Overview
Exhibits 106: Immunogenics LLC - Product / Service
Exhibits 107: Immunogenics LLC - Key offerings
Exhibits 108: Johnson and Johnson - Overview
Exhibits 109: Johnson and Johnson - Business segments
Exhibits 110: Johnson and Johnson - Key news
Exhibits 111: Johnson and Johnson - Key offerings
Exhibits 112: Johnson and Johnson - Segment focus
Exhibits 113: Sanofi - Overview
Exhibits 114: Sanofi - Business segments
Exhibits 115: Sanofi - Key news
Exhibits 116: Sanofi - Key offerings
Exhibits 117: Sanofi - Segment focus
Exhibits 118: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits 119: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits 120: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits 121: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits 122: Inclusions checklist
Exhibits 123: Exclusions checklist
Exhibits 124: Currency conversion rates for US$
Exhibits 125: Research methodology
Exhibits 126: Validation techniques employed for market sizing
Exhibits 127: Information sources
Exhibits 128: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global celiac diseases drugs market: 9 Meters Biopharma Inc., Adaptive Biotechnologies Corp., Almirall SA, Amgen Inc., AMYRA Biotech AG, Avaxia Biologics Inc., BioLineRx Ltd., Bristol Myers Squibb Co., Calypso Biotech, GlaxoSmithKline Plc, Glenmark Pharmaceuticals Ltd, Immunogenics LLC, Johnson and Johnson, Precigen Inc., Sanofi, Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., Vactech Oy, Zedira GmbH, and Artielle Immunotherapeutics Inc.

Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is inorganic growth strategies.`

According to the report, one of the major drivers for this market is the higher consumption of gluten-containing food.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • 9 Meters Biopharma Inc.
  • Adaptive Biotechnologies Corp.
  • Almirall SA
  • Amgen Inc.
  • AMYRA Biotech AG
  • Avaxia Biologics Inc.
  • BioLineRx Ltd.
  • Bristol Myers Squibb Co.
  • Calypso Biotech
  • GlaxoSmithKline Plc
  • Glenmark Pharmaceuticals Ltd
  • Immunogenics LLC
  • Johnson and Johnson
  • Precigen Inc.
  • Sanofi
  • Takeda Pharmaceutical Co. Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Vactech Oy
  • Zedira GmbH
  • Artielle Immunotherapeutics Inc